https://www.avient.com/sites/default/files/resources/TRA%2520-%25202016%2520Plan%2520Summary.pdf
Materials
or feedstock substitution, Product design or reformulation, etc.).
Materials or feedstock substitution
Empty
Product design or reformulation
Empty
Equipment or process modifications
Empty
Spill or leak prevention
Empty
Onsite reuse, recycling or recovery
Empty
Improved inventory management or purchasing techniques
Empty
Good operator practice or training
About us News Contact us Stay connected
HEALTH
healthycanadians.gc.ca
TRAVEL
travel.gc.ca
SERVICE CANADA
servicecanada.gc.ca
JOBS
jobbank.gc.ca
ECONOMY
actionplan.gc.ca
Canada.gc.ca
Terms and Conditions Transparency
Version: 3.13.0
Empty
Identify at least one reason why no option to reduce the use or creation of this substance was
implemented at your facility:
Select the applicable reason or reasons **
There are no alternative processes and/or equipment identified, New equipment and/or processes were investigated, however, deemed
unfeasible
Explanation of the reasons why no option will be implemented
Rationale for why the listed options were chosen for implementation
General description of any actions undertaken by the owner and operator of the facility to reduce the use and creation of the toxic substance
at the facility that are outside of the plan
License Number of the toxic substance reduction planner who made recommendations in the toxic substance reduction plan for this
substance (format TSRPXXXX): *
TSRP0123
Name of the toxic substance reduction planner who made recommendations in the toxic substance reduction plan for this substance (First
Name Last Name)
Daryl Chartrand
License Number of the toxic substance reduction planner who has certified the toxic substance reduction plan for this substance (format
TSRPXXXX): *
TSRP0123
Name of the toxic substance reduction planner who has certified the toxic substance reduction plan for this substance (First Name Last
Name)
Daryl Chartrand
What version of the plan is this summary based on?
https://www.avient.com/sites/default/files/2022-05/Compensation Committee Charter (REV 10-2019).pdf
General Purposes
The general purposes of the Committee are to:
• Develop the Company’s overall executive compensation philosophy and objectives;
• Discharge the Board’s responsibilities relating to compensation of the Company’s executive
officers and, further, to assist the Board in the discharge of its fiduciary responsibilities with
regard to establishment of policies governing, and the implementation of, all aspects of
remuneration throughout the Company, including benefits and perquisites of executive
officers of the Company and any other employees designated by the Committee as key
employees of the Company and its subsidiaries;
• Discharge similar responsibilities with respect to the remuneration of non-employee
directors;
• Review and discuss with management the Company’s disclosures in the Compensation
Discussion and Analysis (the “CD&A”) required by rules and regulations of the Securities
and Exchange Commission (the “SEC”) and recommend to the Board whether the CD&A
should be included in the Company’s proxy statement or other applicable SEC filings;
• Prepare a Compensation Committee Report for inclusion in the Company’s applicable filings
with the SEC that complies with the rules and regulations of the SEC; and
• Provide policy guidance and oversight on significant human resource policies and practices.
Independence Assessment of Outside Advisers
• The Committee may select a compensation consultant, legal counsel or other adviser to the
Committee or receive advice from a compensation consultant, legal counsel or other adviser
(other than in-house legal counsel or any compensation consultant, legal counsel or other
adviser whose role is limited to the following activities for which no disclosure would be
required under Item 407(e)(3)(iii) of Regulation S-K: consulting on any broad-based plan
that does not discriminate in scope, terms, or operation, in favor of executive officers or
directors of the Company, and that is available generally to all salaried employees; or
providing information that either is not customized for a particular company or that is
customized based on parameters that are not developed by the compensation consultant, and
about which the compensation consultant does not provide advice) only after taking into
consideration all factors relevant to that person’s independence from management, including
the following:
• the provision of other services to the Company by the employer of the compensation
consultant, legal counsel or other adviser;
5
• the amount of fees received from the Company by the employer of the compensation
consultant, legal counsel or other adviser, as a percentage of the total revenue of the
employer of the compensation consultant, legal counsel or other adviser;
• the policies and procedures of the employer of the compensation consultant, legal counsel
or other adviser that are designed to prevent conflicts of interest;
• any business or personal relationship of the compensation consultant, legal counsel or
other adviser with a member of the Committee;
• any stock of the Company owned by the compensation consultant, legal counsel or other
adviser; and
• any business or personal relationship of the compensation consultant, legal counsel, other
adviser or the employer of the adviser with an executive officer of the Company
https://www.avient.com/sites/default/files/2024-09/Compensation Committee Charter July 2024.pdf
General Purposes
The general purposes of the Committee are to:
• Oversee the Company’s overall executive compensation philosophy and objectives;
• Discharge the Board’s responsibilities relating to compensation of the Company’s executive
officers (for purposes of this Charter, “executive officers” means the Company’s Section 16
“officers” as defined under Rule 16a-1(f) under the Securities Exchange Act of 1934, as
amended);
• Assist the Board in the discharge of its fiduciary responsibilities with regard to establishment
of policies governing, and the implementation of, all aspects of executive officer
compensation throughout the Company, including benefits and perquisites, and
compensation for any other employees designated by the Committee for such purposes;
• Discharge similar responsibilities with respect to the compensation of non-employee
directors;
• Review and discuss with management the Company’s disclosures in the Compensation
Discussion and Analysis (the “CD&A”) required by rules and regulations of the Securities
and Exchange Commission (the “SEC”) and recommend to the Board whether the CD&A
should be included in the Company’s proxy statement or other applicable SEC filings;
• Prepare a Compensation Committee Report for inclusion in the Company’s applicable filings
with the SEC that complies with the rules and regulations of the SEC; and
• Provide policy guidance and oversight on significant human resource policies and practices.
2
Duties and Responsibilities
The Committee will:
Executive Compensation and Incentives
Independence Assessment of Outside Advisers
• The Committee may select a compensation consultant, legal counsel or other adviser to the
Committee or receive advice from a compensation consultant, legal counsel or other adviser
(other than in-house legal counsel or any compensation consultant, legal counsel or other
adviser whose role is limited to the following activities for which no disclosure would be
required under Item 407(e)(3)(iii) of Regulation S-K: consulting on any broad-based plan
that does not discriminate in scope, terms, or operation, in favor of executive officers or
directors of the Company, and that is available generally to all salaried employees; or
providing information that either is not customized for a particular company or that is
customized based on parameters that are not developed by the compensation consultant, and
about which the compensation consultant does not provide advice) only after taking into
consideration all factors relevant to that person’s independence from management, including
the following:
5
• the provision of other services to the Company by the employer of the compensation
consultant, legal counsel or other adviser;
• the amount of fees received from the Company by the employer of the compensation
consultant, legal counsel or other adviser, as a percentage of the total revenue of the
employer of the compensation consultant, legal counsel or other adviser;
• the policies and procedures of the employer of the compensation consultant, legal counsel
or other adviser that are designed to prevent conflicts of interest;
• any business or personal relationship of the compensation consultant, legal counsel or
other adviser with a member of the Committee;
• any stock of the Company owned by the compensation consultant, legal counsel or other
adviser; and
• any business or personal relationship of the compensation consultant, legal counsel, other
adviser or the employer of the adviser with an executive officer of the Company
https://www.avient.com/sites/default/files/2022-10/Tossiat-IATF 16949-2016 POLYONE FRANCE SAS.pdf
and the applicable customer specific requirements
Revision:11
For Bureau Veritas Certification Holding, Le Triangle de l'Arche, 8 Cours du Triangle - 92800 Puteaux - France
None
Bureau Veritas Certification Certificate N°: FR072877FR072877- IATF- IATF
IATF Certificate N°: 442787442787
Date Of Expiration: 01-February-202501-February-2025
Date Of Certification: 02-February-202202-February-2022
PRODUCT(S) DELIVEREDPRODUCT(S) DELIVERED
colour with additive concentrates for thermoplastic resins
and speciality compounds obtained by mixing and extrusion
PERMITTED EXCLUSION(S)PERMITTED EXCLUSION(S)
SCOPESCOPE
Design and manufacturing
Bureau Veritas Certification certify that the Quality Management System of the above organisation
has been audited and found to be in accordance with the requirements of
Route de la Vavrette, 01250, TOSSIAT FranceRoute de la Vavrette, 01250, TOSSIAT France
PolyOne France TossiatPolyOne France Tossiat
Awarded to
Certificate of ApprovalCertificate of Approval
https://e-cer.bureauveritas.com/FMSNR3ILR1QPBBMGXNKFUDB2LWB28AYDXJNZADBZ8WDH3QYML73QK0B7L7V6CZQPGPGDYLG2UVXWEPJVT4Q0E4Z0DOKSEXCP0BNO7K2WUHCQB2Q9ORVVTV4F9DTN2UI35L
https://e-cer.bureauveritas.com/FMSNR3ILR1QPBBMGXNKFUDB2LWB28AYDXJNZADBZ8WDH3QYML73QK0B7L7V6CZQPGPGDYLG2UVXWEPJVT4Q0E4Z0DOKSEXCP0BNO7K2WUHCQB2Q9ORVVTV4F9DTN2UI35L
https://e-cer.bureauveritas.com/FMSNR3ILR1QPBBMGXNKFUDB2LWB28AYDXJNZADBZ8WDH3QYML73QK0B7L7V6CZQPGPGDYLG2UVXWEPJVT4Q0E4Z0DOKSEXCP0BNO7K2WUHCQB2Q9ORVVTV4F9DTN2UI35L
https://e-cer.bureauveritas.com/FMSNR3ILR1QPBBMGXNKFUDB2LWB28AYDXJNZADBZ8WDH3QYML73QK0B7L7V6CZQPGPGDYLG2UVXWEPJVT4Q0E4Z0DOKSEXCP0BNO7K2WUHCQB2Q9ORVVTV4F9DTN2UI35L
https://e-cer.bureauveritas.com/FMSNR3ILR1QPBBMGXNKFUDB2LWB28AYDXJNZADBZ8WDH3QYML73QK0B7L7V6CZQPGPGDYLG2UVXWEPJVT4Q0E4Z0DOKSEXCP0BNO7K2WUHCQB2Q9ORVVTV4F9DTN2UI35L
https://e-cer.bureauveritas.com/FMSNR3ILR1QPBBMGXNKFUDB2LWB28AYDXJNZADBZ8WDH3QYML73QK0B7L7V6CZQPGPGDYLG2UVXWEPJVT4Q0E4Z0DOKSEXCP0BNO7K2WUHCQB2Q9ORVVTV4F9DTN2UI35L
https://e-cer.bureauveritas.com/FMSNR3ILR1QPBBMGXNKFUDB2LWB28AYDXJNZADBZ8WDH3QYML73QK0B7L7V6CZQPGPGDYLG2UVXWEPJVT4Q0E4Z0DOKSEXCP0BNO7K2WUHCQB2Q9ORVVTV4F9DTN2UI35L
REMOTE SUPPORT FUNCTION(S)REMOTE SUPPORT FUNCTION(S)
(The official document is in English.
https://www.avient.com/sites/default/files/2020-12/maxxam-fr-case-study.pdf
After delivering
polypropylene-based samples from the Maxxam™ FR line
for immediate trial, the Avient team also worked with
the manufacturer to help them determine the best pair
combination design.
https://www.avient.com/sites/default/files/2023-07/Versaflex HC _ Versaflex HC BIO - BT Series Product Overview.pdf
Offering reliable performance, optical clarity
and expanded design freedom, these medical-
grade TPEs may be customized to meet specific
regulatory demands or application needs.
https://www.avient.com/sites/default/files/2024-06/Smartbatch FX for Paint Replacement.pdf
Our
Avient Design engineering experts can support
as well with the computer aided simulation
of molded-in-color metallic parts to minimize
surface defects.
https://www.avient.com/sites/default/files/2024-03/SEM Global Nylon Product Selection Guide_A4.pdf
NYMAX/BERGAMID PRIME NYLON GRADES
The Nymax/Bergamid series of PA6 and PA66 polymers are
designed to meet critical performance requirements for
demanding applications.
https://www.avient.com/sites/default/files/2023-01/GlasArmor Ballistic Resistant Panels Case Study.pdf
Avient and Southern States worked together to develop
a modular design using GlasArmor ballistic panels.
https://www.avient.com/sites/default/files/2023-03/Mevopur Healthcare Functional Additives Antistatic Application Bulletin_0.pdf
Please be aware that there are certain applications Avient’s Mevopur products have not been designed for, nor are they promoted or intended for use in: including, but not limited to long-term or permanent
implants, birth control devices, or plastic surgery.